LitCovid-sample-Enju  

PMC:7199903 / 6390-7139 JSONTXT 19 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T1068 0-2 TO denotes To
T1069 3-12 VB denotes determine
T1070 13-16 DT denotes the
T1071 17-30 JJ denotes site-specific
T1072 31-44 NN denotes glycosylation
T1073 45-47 IN denotes of
T1074 48-58 NN denotes SARS-CoV-2
T1075 59-60 NN denotes S
T1076 60-61 -COMMA- denotes ,
T1077 62-64 PRP denotes we
T1078 65-69 VBD denotes used
T1079 70-77 NN denotes trypsin
T1080 77-78 -COMMA- denotes ,
T1081 79-91 NN denotes chymotrypsin
T1082 91-92 -COMMA- denotes ,
T1083 93-96 CC denotes and
T1084 97-104 JJ denotes α-lytic
T1085 105-113 NN denotes protease
T1086 114-116 TO denotes to
T1087 117-125 VB denotes generate
T1088 126-131 CD denotes three
T1089 132-144 NN denotes glycopeptide
T1090 145-152 NNS denotes samples
T1091 154-159 DT denotes These
T1092 160-169 NNS denotes proteases
T1093 170-174 VBD denotes were
T1094 175-183 VBN denotes selected
T1095 184-186 TO denotes to
T1096 187-195 VB denotes generate
T1097 196-209 NNS denotes glycopeptides
T1098 210-214 WDT denotes that
T1099 215-222 VBP denotes contain
T1100 223-224 DT denotes a
T1101 225-231 JJ denotes single
T1102 232-240 JJ denotes N-linked
T1103 241-247 NN denotes glycan
T1104 248-254 NN denotes sequon
T1105 256-259 DT denotes The
T1106 260-273 NNS denotes glycopeptides
T1107 274-278 VBD denotes were
T1108 279-287 VBN denotes analyzed
T1109 288-290 IN denotes by
T1110 291-297 JJ denotes liquid
T1111 298-317 NN denotes chromatography–mass
T1112 318-330 NN denotes spectrometry
T1113 330-331 -COMMA- denotes ,
T1114 332-335 CC denotes and
T1115 336-339 DT denotes the
T1116 340-346 NN denotes glycan
T1117 347-359 NNS denotes compositions
T1118 360-364 VBD denotes were
T1119 365-375 VBN denotes determined
T1120 376-379 IN denotes for
T1121 380-383 DT denotes all
T1122 384-386 CD denotes 22
T1123 387-395 JJ denotes N-linked
T1124 396-402 NN denotes glycan
T1125 403-408 NNS denotes sites
T1126 409-410 -LRB- denotes (
T1127 410-414 NN denotes Fig.
T1128 415-416 CD denotes 2
T1129 416-417 -RRB- denotes )
T1130 419-421 TO denotes To
T1131 422-428 VB denotes convey
T1132 429-432 DT denotes the
T1133 433-437 JJ denotes main
T1134 438-448 NN denotes processing
T1135 449-457 NNS denotes features
T1136 458-460 IN denotes at
T1137 461-465 DT denotes each
T1138 466-470 NN denotes site
T1139 470-471 -COMMA- denotes ,
T1140 472-475 DT denotes the
T1141 476-486 NNS denotes abundances
T1142 487-489 IN denotes of
T1143 490-494 DT denotes each
T1144 495-501 NN denotes glycan
T1145 502-505 VBP denotes are
T1146 506-512 VBN denotes summed
T1147 513-517 IN denotes into
T1148 518-535 JJ denotes oligomannose-type
T1149 535-536 -COMMA- denotes ,
T1150 537-548 JJ denotes hybrid-type
T1151 548-549 -COMMA- denotes ,
T1152 550-553 CC denotes and
T1153 554-564 NNS denotes categories
T1154 565-567 IN denotes of
T1155 568-580 JJ denotes complex-type
T1156 581-594 NN denotes glycosylation
T1157 595-600 VBN denotes based
T1158 601-603 IN denotes on
T1159 604-613 NN denotes branching
T1160 614-617 CC denotes and
T1161 618-630 NN denotes fucosylation
T1162 632-635 DT denotes The
T1163 636-644 VBN denotes detailed
T1164 644-645 -COMMA- denotes ,
T1165 646-654 VBD denotes expanded
T1166 655-661 NNS denotes graphs
T1167 662-669 VBG denotes showing
T1168 670-673 DT denotes the
T1169 674-681 JJ denotes diverse
T1170 682-687 NN denotes range
T1171 688-690 IN denotes of
T1172 691-697 NN denotes glycan
T1173 698-710 NNS denotes compositions
T1174 711-714 VBP denotes are
T1175 715-724 VBN denotes presented
T1176 725-727 IN denotes in
T1177 728-733 NN denotes table
T1178 734-736 NN denotes S1
T1179 737-740 CC denotes and
T1180 741-744 NN denotes fig
T1181 746-748 NN denotes S2
R1072 T1069 T1068 arg1Of determine,To
R1073 T1078 T1068 modOf used,To
R1074 T1072 T1069 arg2Of glycosylation,determine
R1075 T1072 T1070 arg1Of glycosylation,the
R1076 T1072 T1071 arg1Of glycosylation,site-specific
R1077 T1072 T1073 arg1Of glycosylation,of
R1078 T1075 T1073 arg2Of S,of
R1079 T1075 T1074 arg1Of S,SARS-CoV-2
R1080 T1078 T1076 arg1Of used,","
R1081 T1077 T1078 arg1Of we,used
R1082 T1083 T1078 arg2Of and,used
R1083 T1087 T1078 arg3Of generate,used
R1084 T1079 T1080 arg1Of trypsin,","
R1085 T1081 T1080 arg2Of chymotrypsin,","
R1086 T1083 T1082 arg1Of and,","
R1087 T1080 T1083 arg1Of ",",and
R1088 T1085 T1083 arg2Of protease,and
R1089 T1085 T1084 arg1Of protease,α-lytic
R1090 T1087 T1086 arg1Of generate,to
R1091 T1077 T1087 arg1Of we,generate
R1092 T1090 T1087 arg2Of samples,generate
R1093 T1090 T1088 arg1Of samples,three
R1094 T1090 T1089 arg1Of samples,glycopeptide
R1095 T1092 T1091 arg1Of proteases,These
R1096 T1092 T1093 arg1Of proteases,were
R1097 T1094 T1093 arg2Of selected,were
R1098 T1092 T1094 arg2Of proteases,selected
R1099 T1096 T1094 arg3Of generate,selected
R1100 T1096 T1095 arg1Of generate,to
R1101 T1092 T1096 arg1Of proteases,generate
R1102 T1097 T1096 arg2Of glycopeptides,generate
R1103 T1097 T1098 arg1Of glycopeptides,that
R1104 T1097 T1099 arg1Of glycopeptides,contain
R1105 T1104 T1099 arg2Of sequon,contain
R1106 T1104 T1100 arg1Of sequon,a
R1107 T1104 T1101 arg1Of sequon,single
R1108 T1104 T1102 arg1Of sequon,N-linked
R1109 T1104 T1103 arg1Of sequon,glycan
R1110 T1106 T1105 arg1Of glycopeptides,The
R1111 T1106 T1107 arg1Of glycopeptides,were
R1112 T1108 T1107 arg2Of analyzed,were
R1113 T1112 T1108 arg1Of spectrometry,analyzed
R1114 T1106 T1108 arg2Of glycopeptides,analyzed
R1115 T1112 T1109 arg2Of spectrometry,by
R1116 T1112 T1110 arg1Of spectrometry,liquid
R1117 T1112 T1111 arg1Of spectrometry,chromatography–mass
R1118 T1114 T1113 arg1Of and,","
R1119 T1108 T1114 arg1Of analyzed,and
R1120 T1119 T1114 arg2Of determined,and
R1121 T1117 T1115 arg1Of compositions,the
R1122 T1117 T1116 arg1Of compositions,glycan
R1123 T1117 T1118 arg1Of compositions,were
R1124 T1119 T1118 arg2Of determined,were
R1125 T1117 T1119 arg2Of compositions,determined
R1126 T1119 T1120 arg1Of determined,for
R1127 T1125 T1120 arg2Of sites,for
R1128 T1122 T1121 arg1Of 22,all
R1129 T1125 T1122 arg1Of sites,22
R1130 T1125 T1123 arg1Of sites,N-linked
R1131 T1125 T1124 arg1Of sites,glycan
R1132 T1125 T1126 arg1Of sites,(
R1133 T1127 T1126 arg2Of Fig.,(
R1134 T1129 T1126 arg3Of ),(
R1135 T1127 T1128 arg1Of Fig.,2
R1136 T1131 T1130 arg1Of convey,To
R1137 T1146 T1130 modOf summed,To
R1138 T1141 T1131 arg1Of abundances,convey
R1139 T1135 T1131 arg2Of features,convey
R1140 T1135 T1132 arg1Of features,the
R1141 T1135 T1133 arg1Of features,main
R1142 T1135 T1134 arg1Of features,processing
R1143 T1131 T1136 arg1Of convey,at
R1144 T1138 T1136 arg2Of site,at
R1145 T1138 T1137 arg1Of site,each
R1146 T1146 T1139 arg1Of summed,","
R1147 T1141 T1140 arg1Of abundances,the
R1148 T1141 T1142 arg1Of abundances,of
R1149 T1144 T1142 arg2Of glycan,of
R1150 T1144 T1143 arg1Of glycan,each
R1151 T1141 T1145 arg1Of abundances,are
R1152 T1146 T1145 arg2Of summed,are
R1153 T1141 T1146 arg2Of abundances,summed
R1154 T1146 T1147 arg1Of summed,into
R1155 T1152 T1147 arg2Of and,into
R1156 T1152 T1148 arg1Of and,oligomannose-type
R1157 T1152 T1149 arg1Of and,","
R1158 T1152 T1151 arg1Of and,","
R1159 T1150 T1152 arg1Of hybrid-type,and
R1160 T1153 T1152 arg2Of categories,and
R1161 T1153 T1154 arg1Of categories,of
R1162 T1156 T1154 arg2Of glycosylation,of
R1163 T1156 T1155 arg1Of glycosylation,complex-type
R1164 T1153 T1157 arg1Of categories,based
R1165 T1158 T1157 arg2Of on,based
R1166 T1160 T1158 arg2Of and,on
R1167 T1159 T1160 arg1Of branching,and
R1168 T1161 T1160 arg2Of fucosylation,and
R1169 T1165 T1164 arg1Of expanded,","
R1170 T1166 T1165 arg2Of graphs,expanded
R1171 T1166 T1167 arg1Of graphs,showing
R1172 T1170 T1167 arg2Of range,showing
R1173 T1170 T1168 arg1Of range,the
R1174 T1170 T1169 arg1Of range,diverse
R1175 T1170 T1171 arg1Of range,of
R1176 T1173 T1171 arg2Of compositions,of
R1177 T1173 T1172 arg1Of compositions,glycan
R1178 T1175 T1174 arg2Of presented,are
R1179 T1175 T1176 arg1Of presented,in
R1180 T1179 T1176 arg2Of and,in
R1181 T1179 T1177 arg1Of and,table
R1182 T1178 T1179 arg1Of S1,and
R1183 T1180 T1179 arg2Of fig,and